Related Experiment Videos
[Acute myeloid leukemia with infective endocarditis].
Noriko Doki1, Takafumi Matsushima, Norifumi Tsukamoto
1Third Department of Internal Medicine, Gunma University, School of Medicine.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|November 5, 2002
Summary
This case study details a patient with acute myeloid leukemia who developed fatal infective endocarditis. Despite treatment, multidrug-resistant bacteria led to severe valve damage and death.
Area of Science:
- Hematology
- Infectious Diseases
- Cardiology
Background:
- Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow.
- Infective endocarditis is a serious infection of the heart valves.
- Comorbidities like mitral stenosis increase cardiac risk.
Observation:
- A 67-year-old male with AML (M2) presented with mitral stenosis and atrial fibrillation.
- The patient achieved remission but developed sepsis from coagulase-negative staphylococcus.
- Later, multidrug-resistant Staphylococcus epidermidis caused infective endocarditis with mitral valve vegetation.
Findings:
- Despite antibiotics and valve replacement surgery, the patient succumbed to cardiac tamponade.
- This case highlights the severe complications of infective endocarditis in immunocompromised patients.
- Multidrug-resistant organisms pose a significant challenge in managing these infections.
Implications:
- Aggressive management and early detection are crucial for patients with AML and cardiac conditions.
- The rise of multidrug-resistant bacteria necessitates novel therapeutic strategies.
- Understanding the interplay between hematologic malignancy and infectious complications is vital for patient outcomes.